PlainRecalls
FDA Drug Moderate Class II Terminated

Amitiza (lubiprostone) capsules, 8 mcg, 60-count bottle, Rx only, Manufactured by: Sucampo Pharma Americas, LLC, NDC 64764-080-60

Reported: May 29, 2019 Initiated: May 13, 2019 #D-1294-2019

Product Description

Amitiza (lubiprostone) capsules, 8 mcg, 60-count bottle, Rx only, Manufactured by: Sucampo Pharma Americas, LLC, NDC 64764-080-60

Reason for Recall

Labeling: Label mix-up. Amitiza 8 mcg capsules are being recalled because 24 mcg capsules were found in a 8 mcg trade 60 ct. bottle. Amitiza 24 mcg capsules are being recalled because a sealed 60 ct. bottle contained only 8 mcg capsules, this incident is being considered as a labeling mix-up issue.

Details

Units Affected
89,808 bottles
Distribution
US Nationwide
Location
Bedminster, NJ

Frequently Asked Questions

What product was recalled?
Amitiza (lubiprostone) capsules, 8 mcg, 60-count bottle, Rx only, Manufactured by: Sucampo Pharma Americas, LLC, NDC 64764-080-60. Recalled by MALLINCKRODT PHARMACEUTICALS. Units affected: 89,808 bottles.
Why was this product recalled?
Labeling: Label mix-up. Amitiza 8 mcg capsules are being recalled because 24 mcg capsules were found in a 8 mcg trade 60 ct. bottle. Amitiza 24 mcg capsules are being recalled because a sealed 60 ct. bottle contained only 8 mcg capsules, this incident is being considered as a labeling mix-up issue.
Which agency issued this recall?
This recall was issued by the FDA Drug on May 29, 2019. Severity: Moderate. Recall number: D-1294-2019.